GlaxoSmithKline PLC (GSK) Social Stream



GlaxoSmithKline PLC (GSK): $39.34

0.06 (+0.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Glaxosmithkline Plc (GSK) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Glaxosmithkline Plc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
19 $60.58 $33.51 $46.02 $39.22 17.34%

The Trend in the Analyst Price Target


Over the past 143 days, GSK's average price target has gone down $1.64.

Over the past 177 days, GSK's average upside potential has been 25.94%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-29 19 60.58 33.51 46.02 37.07 24.14%
2020-11-28 19 60.58 33.51 46.02 37.07 24.14%
2020-11-19 19 60.58 33.51 45.97 37.14 23.77%
2020-11-13 19 60.58 33.51 45.85 38.30 19.71%
2020-10-29 18 60.58 33.51 46.09 33.96 35.72%
2020-10-02 18 60.41 40.14 47.99 37.24 28.87%
2020-09-23 17 60.41 40.14 48.39 37.79 28.05%
2020-09-17 17 60.41 40.14 48.61 39.47 23.16%
2020-09-03 16 57.04 38.62 47.88 NA NA%
2020-08-28 16 57.04 38.62 47.75 NA NA%
2020-08-19 16 57.04 38.62 47.79 NA NA%
2020-08-12 17 57.04 38.62 48.20 NA NA%
2020-08-05 17 57.04 38.62 48.27 NA NA%
2020-07-25 17 56.08 39.21 47.99 NA NA%
2020-07-16 17 55.35 39.11 47.75 NA NA%
2020-07-09 17 55.35 39.11 47.66 NA NA%
2020-07-04 17 55.35 38.64 47.40 NA NA%
2020-06-25 18 55.35 38.46 47.28 NA NA%
2020-06-18 18 55.35 38.49 47.15 NA NA%
2020-06-11 18 55.35 39.19 47.15 NA NA%
2020-06-05 18 55.35 39.08 47.15 NA NA%

GSK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


GSK's average broker recommendation rating improved by 0.58 over the prior 39 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The number of analysts covering the stock of GSK is higher than 92.04% of all US stocks.
  • Glaxosmithkline Plc's variance in analysts' estimates is lower than 17.83% of all US stocks.
  • Glaxosmithkline Plc's upside potential (average analyst target price relative to current price) is higher than 13.15% of Pharmaceutical Products stocks.
  • Glaxosmithkline Plc's average analyst price target is greater than 76.22% of Pharmaceutical Products stocks.

Make investment decisions regarding GSK using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7643 seconds.